Home > Publications Database > RAB5 is a host dependency factor for the generation of SARS-CoV-2 replication organelles. > print |
001 | 278658 | ||
005 | 20250601001327.0 | ||
024 | 7 | _ | |a 10.1128/mbio.03314-24 |2 doi |
024 | 7 | _ | |a pmid:40167317 |2 pmid |
024 | 7 | _ | |a pmc:PMC12077180 |2 pmc |
024 | 7 | _ | |a 2161-2129 |2 ISSN |
024 | 7 | _ | |a 2150-7511 |2 ISSN |
024 | 7 | _ | |a altmetric:177345968 |2 altmetric |
037 | _ | _ | |a DZNE-2025-00614 |
041 | _ | _ | |a English |
082 | _ | _ | |a 570 |
100 | 1 | _ | |a Chen, Yuexuan |b 0 |
245 | _ | _ | |a RAB5 is a host dependency factor for the generation of SARS-CoV-2 replication organelles. |
260 | _ | _ | |a Washington, DC |c 2025 |b American Society for Microbiology |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1748429112_1773 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a threat due to the emergence of variants with increased transmissibility and enhanced escape from immune responses. Like other coronaviruses before, SARS-CoV-2 likely emerged after its transmission from bats. The successful propagation of SARS-CoV-2 in humans might have been facilitated by usurping evolutionarily conserved cellular factors to execute crucial steps in its life cycle, such as the generation of replication organelles-membrane structures where coronaviruses assemble their replication-transcription complex. In this study, we found that RAB5, which is highly conserved across mammals, is a critical host dependency factor for the replication of the SARS-CoV-2 genome. Our results also suggest that SARS-CoV-2 uses RAB5+ membranes to build replication organelles with the aid of COPB1, a component of the COP-I complex, and that the virus protein NSP6 participates in this process. Hence, targeting NSP6 represents a promising approach to interfere with SARS-CoV-2 RNA synthesis and halt its propagation.IMPORTANCEIn this study, we sought to identify the host dependency factors that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses for the generation of replication organelles: cellular membranous structures that SARS-CoV-2 builds in order to support the replication and transcription of its genome. We uncovered that RAB5 is an important dependency factor for SARS-CoV-2 replication and the generation of replication organelles, and that the viral protein NSP6 participates in this process. Hence, NSP6 represents a promising target to halt SARS-CoV-2 replication. |
536 | _ | _ | |a 351 - Brain Function (POF4-351) |0 G:(DE-HGF)POF4-351 |c POF4-351 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
650 | _ | 7 | |a COP-I |2 Other |
650 | _ | 7 | |a COPB1 |2 Other |
650 | _ | 7 | |a NSP6 |2 Other |
650 | _ | 7 | |a RAB5 |2 Other |
650 | _ | 7 | |a SARS-CoV-2 |2 Other |
650 | _ | 7 | |a replication organelle |2 Other |
650 | _ | 7 | |a rab5 GTP-Binding Proteins |0 EC 3.6.5.2 |2 NLM Chemicals |
650 | _ | 7 | |a RAB5C protein, human |0 EC 3.6.1.- |2 NLM Chemicals |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a rab5 GTP-Binding Proteins: metabolism |2 MeSH |
650 | _ | 2 | |a rab5 GTP-Binding Proteins: genetics |2 MeSH |
650 | _ | 2 | |a Virus Replication |2 MeSH |
650 | _ | 2 | |a SARS-CoV-2: physiology |2 MeSH |
650 | _ | 2 | |a SARS-CoV-2: genetics |2 MeSH |
650 | _ | 2 | |a Animals |2 MeSH |
650 | _ | 2 | |a COVID-19: virology |2 MeSH |
650 | _ | 2 | |a Host-Pathogen Interactions |2 MeSH |
650 | _ | 2 | |a Vero Cells |2 MeSH |
650 | _ | 2 | |a Chlorocebus aethiops |2 MeSH |
650 | _ | 2 | |a Viral Replication Compartments: metabolism |2 MeSH |
700 | 1 | _ | |a Klute, Susanne |0 P:(DE-2719)9003510 |b 1 |u dzne |
700 | 1 | _ | |a Sparrer, Konstantin Maria Johannes |0 P:(DE-2719)9003481 |b 2 |u dzne |
700 | 1 | _ | |a Serra-Moreno, Ruth |0 0000-0002-1923-6414 |b 3 |
773 | _ | _ | |a 10.1128/mbio.03314-24 |g Vol. 16, no. 5, p. e03314-24 |0 PERI:(DE-600)2557172-2 |n 5 |p e0331424 |t mBio |v 16 |y 2025 |x 2161-2129 |
856 | 4 | _ | |u https://pub.dzne.de/record/278658/files/DZNE-2025-00614%20SUP.pdf |
856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/278658/files/DZNE-2025-00614.pdf |
856 | 4 | _ | |x pdfa |u https://pub.dzne.de/record/278658/files/DZNE-2025-00614%20SUP.pdf?subformat=pdfa |
856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/278658/files/DZNE-2025-00614.pdf?subformat=pdfa |
909 | C | O | |o oai:pub.dzne.de:278658 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 1 |6 P:(DE-2719)9003510 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)9003481 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-351 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Brain Function |x 0 |
914 | 1 | _ | |y 2025 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-18 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-18 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-18 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-18 |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b MBIO : 2022 |d 2024-12-18 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-03-14T07:11:37Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-03-14T07:11:37Z |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-18 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2024-12-18 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-18 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2023-03-14T07:11:37Z |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2024-12-18 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b MBIO : 2022 |d 2024-12-18 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-18 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-18 |
920 | 1 | _ | |0 I:(DE-2719)1910003 |k AG Sparrer |l Neurovirology and Neuroinflammation |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-2719)1910003 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|